| 2025-03-06 20:31 | CC:MDCX | Medicus Pharma Ltd. | 5.69 | News Release200 | Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering |
| 2025-03-06 07:31 | CC:MDCX | Medicus Pharma Ltd. | 5.69 | News Release200 | Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) |
| 2025-02-27 07:32 | CC:MDCX | Medicus Pharma Ltd. | 5.69 | News Release200 | Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) |
| 2025-02-20 16:35 | CC:MDCX | Medicus Pharma Ltd (2) | 5.70 | Shares Delisted from TSX-V223 | Medicus Pharma to be delisted from TSX-V |
| 2025-02-14 14:32 | CC:MDCX | Medicus Pharma Ltd (2) | 3.90 | News Release200 | Medicus randomizes 50% of patients for SKNJCT-003 study |
| 2025-02-11 17:32 | CC:MDCX | Medicus Pharma Ltd (2) | 3.85 | News Release200 | Medicus Pharma to delist from TSX-V, enters SEPA |
| 2024-12-18 16:42 | CC:MDCX | Medicus Pharma Ltd (2) | 3.95 | Private Placement250 | Medicus Pharma 970,000-share private placement |
| 2024-12-12 16:05 | CC:MDCX | Medicus Pharma Ltd (2) | 3.95 | News Release200 | Medicus's D-MNA receives MUMS designation from FDA |
| 2024-12-02 18:25 | CC:MDCX | Medicus Pharma Ltd (2) | 3.60 | News Release200 | Medicus to expand phase 2 study of basal cell carcinoma |
| 2024-11-22 21:18 | CC:MDCX | Medicus Pharma Ltd (2) | 3.07 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-11-22 21:12 | CC:MDCX | Medicus Pharma Ltd (2) | 3.07 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-11-18 16:10 | CC:MDCX | Medicus Pharma Ltd (2) | 2.90 | News Release200 | Medicus appoints Mehmud as chief medical officer |
| 2024-11-15 16:59 | CC:MDCX | Medicus Pharma Ltd (2) | 2.90 | News Release200 | Medicus closes $4M (U.S.) initial public offering |
| 2024-11-13 18:55 | CC:MDCX | Medicus Pharma Ltd (2) | 6.49 | News Release200 | Medicus prices U.S. IPO at $4.125 (U.S.) per unit |
| 2024-10-28 13:51 | CC:MDCX | Medicus Pharma Ltd (2) | 3.49 | News Release200 | Medicus Pharma completes 1:2 share rollback |
| 2024-10-28 13:12 | CC:MDCX | Medicus Pharma Ltd. | 3.49 | News Release200 | Canadian Investment Regulatory Organization Trade Resumption - MDCX |
| 2024-10-28 12:36 | CC:MDCX | Medicus Pharma Ltd (2) | 3.49 | Resume Trading385 | Medicus Pharma to resume at 10 a.m. PT |
| 2024-10-25 08:07 | CC:MDCX | Medicus Pharma Ltd. old | 3.49 | News Release200 | Canadian Investment Regulatory Organization Trading Halt - MDCX |
| 2024-10-25 07:59 | CC:MDCX | Medicus Pharma Ltd (2) | 3.49 | Halt Trading170 | Medicus Pharma halted at the open |
| 2024-10-24 18:54 | CC:MDCX | Medicus Pharma Ltd (1) | 3.49 | Rollback291 | Medicus Pharma 1:2 rollback |
| 2024-08-27 15:50 | CC:MDCX | Medicus Pharma Ltd | 2.20 | News Release200 | Medicus enrolls 1st patient in phase 2 clinical trial |
| 2024-08-22 19:57 | CC:MDCX | Medicus Pharma Ltd | 2.31 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-08-22 19:51 | CC:MDCX | Medicus Pharma Ltd | 2.31 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-07-19 21:05 | CC:MDCX | Medicus Pharma Ltd | 2.20 | SEDAR Annual Information Form802 | SEDAR Annual Information Form |
| 2024-07-15 11:43 | CC:MDCX | Medicus Pharma Ltd | 2.26 | News Release200 | Medicus Pharma submits phase 2 clinical protocol to FDA |
| 2024-07-11 19:52 | CC:MDCX | Medicus Pharma Ltd | 2.26 | Private Placement250 | Medicus Pharma 2,922,500-share private placement |
| 2024-07-05 17:13 | CC:MDCX | Medicus Pharma Ltd | 2.40 | Shares for Debt330 | Medicus Pharma 31,345 shares for debt |
| 2024-07-05 17:11 | CC:MDCX | Medicus Pharma Ltd | 2.40 | Private Placement - Debenture255 | Medicus Pharma debenture private placement |
| 2024-07-05 11:33 | CC:MDCX | Medicus Pharma Ltd | 1.49 | News Release200 | Medicus Pharma closes $5.84M (U.S.) private placement |
| 2024-06-26 18:08 | CC:MDCX | Medicus Pharma Ltd | 1.68 | News Release200 | Medicus Pharma arranges $5.84M (U.S.) private placement |
| 2024-05-30 19:26 | CC:MDCX | Medicus Pharma Ltd | 2.00 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-05-30 19:12 | CC:MDCX | Medicus Pharma Ltd | 2.00 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-05-29 11:07 | CC:MDCX | Medicus Pharma Ltd | 2.01 | News Release200 | Medicus files statement for proposed U.S. IPO |
| 2024-05-03 18:13 | CC:MDCX | Medicus Pharma Ltd | 2.10 | News Release200 | Medicus closes first tranche of private placement |
| 2024-04-29 18:21 | CC:MDCX | Medicus Pharma Ltd | 2.25 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-04-29 18:18 | CC:MDCX | Medicus Pharma Ltd | 2.25 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-04-29 16:59 | CC:MDCX | Medicus Pharma Ltd | 2.25 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-04-29 16:47 | CC:MDCX | Medicus Pharma Ltd | 2.25 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-04-26 07:03 | CC:MDCX | Medicus Pharma Ltd | 2.25 | Resume Trading385 | Medicus Pharma resuming at the open |
| 2024-04-25 15:17 | CC:MDCX | Medicus Pharma Ltd | 2.25 | News Release200 | Medicus Pharma to close first tranche of note financing |
| 2024-04-25 09:11 | CC:MDCX | Medicus Pharma Ltd | 2.25 | Halt Trading170 | Medicus Pharma halted at the open |